MHRA Warns of Weight Loss Drug Side Effects

admin
1 Min Read

The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals about the side effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and declared them effective but carrying risks. The House of Lords food, diet, and obesity committee declared a public health emergency on obesity, recommending a tax on junk food and advocating for responsible use of weight loss drugs like semaglutide. They also proposed banning junk food ads and implementing a comprehensive legislative framework to tackle obesity. Dr. Sheena Meredith, a medical writer, editor, and consultant, supports these measures and advocates for prioritizing public health over business interests in discussions on food, diet, and obesity prevention.

Source link

Share This Article
error: Content is protected !!